Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Tissue-Engineered Tumor Models

10/28/2010

Marylou Ingram, M.D., Senior Research Scientist, and Director, In Vitro Systems/Tissue Engineering, Huntington Medical Research Institutes, Pasadena, CA

Scientists at the Huntington Medical Research Institutes have developed a method for reproducibly generating tissue-engineered, 3-D tumor models that contain both tumor cells and stromal elements with a microscopic architecture. The team says the models are so tissue-like that they call them tumor histoids.


 Each histoid is a few tenths of a millimeter in diameter. They are formed by spontaneous interaction of two or more cell types during histoid culture without a support matrix. They also can be produced in quantities large enough for moderately high-throughput drug screening, according to the researchers.


 During this week’s podcast team member Dr. Marylou Ingram discusses in detail the process and tissue-engineering techniques the scientists used to create the novel tumor models. She also describes what makes these particular models so unique. In addition, Dr. Ingram goes over the range of potential applications for their tissue-engineered tumor models.


Related content

New Products

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll